1-3 of 3
Antonio Calles
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Unveiling the Mechanism of Lurbinectedin’s Action and Its Potential in Combination Therapies in Small Cell Lung Cancer

Antonio Calles, Emiliano Calvo, Gema Santamaría Nuñez, Federico Costanzo, María José Guillén, Marta Martinez Diez, Aparna Gupta, Carmen Cuevas, Jean-Marc Egly, Pablo Avilés
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther OF1–OF12.
https://doi.org/10.1158/1535-7163.MCT-24-0050
Published: 30 December 2024
View article titled, Unveiling the Mechanism of Lurbinectedin’s Action and Its Potential in Combination Therapies in Small Cell Lung Cancer
Open the PDF for Unveiling the Mechanism of Lurbinectedin’s Action and Its Potential in Combination Therapies in Small Cell Lung Cancer in another window
Journal Articles

Abstract B145: Clinical features of progression and outcomes with subsequent therapies in patients treated with RET-inhibitors

Arianna Marinello, Wael Salem Zrafi, Giacomo Massa, Fabrizio Tabbò, Fabrizio Citarella, Filippo Gustavo Dall'Olio, Lindsay Colin, Emilio Bria, Giulio Metro, Josè Nicolas Minatta, Antonio Calles, Isabelle Monnet, Marco Tagliamento, Hortense Gaultier De Saint Basile, Nicolas Girard, Arianna Pagliaro, Diego Luigi Cortinovis, Judith Raimbourg, Carol Zanchetta, Giannis Mountzios, Frank Aboubakar Nana, Safae Terrisse, Alessandro Russo, Patricia Iranzo, Clarisse Audigier-Valette, Philippe Rochigneux, Vincent Fallet, Michael Duruisseaux, Sophie Cousin, Florian Guisier, Laura Mezquita, Jordi Remon, Anas Gazzah, David Planchard, Benjamin Besse, Mihaela Aldea
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (12_Supplement): B145.
https://doi.org/10.1158/1535-7163.TARG-23-B145
Published: 01 December 2023
View article titled, Abstract B145: Clinical features of progression and outcomes with subsequent therapies in patients treated with RET-inhibitors
Journal Articles

Abstract A91: A phase I dose-escalation study of bosutinib plus capecitabine in selected advanced solid tumors.

Steven Isakoff, Ding Wang, Mario Campone, Antonio Calles, Nathalie Bardy-Bouxin, Ladan Duvillie, Emiliano Calvo
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (11_Supplement): A91.
https://doi.org/10.1158/1535-7163.TARG-11-A91
Published: 12 November 2011
View article titled, Abstract A91: A phase I dose-escalation study of bosutinib plus capecitabine in selected advanced solid tumors.